Aldeyra Therapeutics (ALDX)
(Delayed Data from NSDQ)
$5.89 USD
-0.15 (-2.48%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.76 -0.13 (-2.21%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/26/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | -75.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.51 |
Next Year | -0.56 |
EPS (TTM) | -0.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 100.00M | 35.61M |
# of Estimates | NA | NA | 1 | 3 |
High Estimate | NA | NA | 100.00M | 67.30M |
Low Estimate | NA | NA | 100.00M | 18.70M |
Year ago Sales | 0.00M | 0.00M | NA | 100.00M |
Year over Year Growth Est. | NA | NA | NA | -64.39% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.25 | -0.51 | -0.56 |
# of Estimates | 2 | 4 | 4 | 4 |
Most Recent Consensus | -0.14 | -0.26 | 0.70 | -0.80 |
High Estimate | -0.14 | -0.16 | 0.70 | 0.50 |
Low Estimate | -0.28 | -0.29 | -1.01 | -0.99 |
Year ago EPS | -0.15 | -0.14 | -0.64 | -0.51 |
Year over Year Growth Est. | -40.00% | -78.57% | 20.31% | -11.27% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 3 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.25 | -0.51 | -0.56 |
7 Days Ago | -0.21 | -0.25 | -0.51 | -0.56 |
30 Days Ago | -0.18 | -0.25 | -0.51 | -0.56 |
60 Days Ago | -0.14 | -0.17 | -0.23 | -0.42 |
90 Days Ago | -0.14 | -0.17 | -0.23 | -0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.25 | -0.51 | -0.56 |
Zacks Consensus Estimate | -0.21 | -0.25 | -0.51 | -0.56 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.08 | -0.14 | -0.15 | NA |
Estimate | -0.08 | -0.21 | NA | -0.31 | NA |
Difference | -0.06 | 0.13 | NA | 0.16 | 0.08 |
Surprise | -75.00% | 61.90% | NA | 51.61% | 12.84% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more